Issue 2/2010

Maspin and Nm23-H1 expression in colorectal cancer (95 — 101)

G. PASZ-WALCZAK, A. SALAGACKA, P. POTEMSKI, E. BALCERCZAK, R. KORDEK, M. MIROWSKI

DOI: 10.4149/neo_2010_02_95

The importance of serum levels of selected biological parameters in the diagnosis, staging and prognosis of multiple myeloma (102 — 110)

V. SCUDLA, T. PIKA, M. BUDIKOVA, J. PETROVA, J. MINARIK, J. BACOVSKY, K. LANGOVA, J. ZIVNA

DOI: 10.4149/neo_2010_02_102

Negative prognostic significance of two or more cytogenetic abnormalities in multiple myeloma patients treated with autologous stem cell transplantation (111 — 117)

H. GRESLIKOVA, R. ZAORALOVA, H. FILKOVA, P. NEMEC, A. OLTOVA, R. KUPSKA, P. RUDOLECKA, J. SMETANA, L. POUR, L. ZAHRADOVA, M. KREJCI, T. BUCHLER, Z. ADAM, R. HAJEK, P. KUGLIK

DOI: 10.4149/neo_2010_02_111

Serum level of IGFBP3 and IGF1/IGFBP3 molar ratio in addition to PSA and single nucleotide polymorphism in PSA and CYP17 gene may contribute to early diagnostics of prostate cancer (118 — 122)

M. TAJTAKOVA, A. PIDANICOVA, L. VALANSKY, L. LACHVAC, V. NAGY, M. SIVONOVA, D. DOBROTA, J. KLIMENT, J. PETROVICOVA

DOI: 10.4149/neo_2010_02_118

Differential gene expression identified in Uigur women cervical squamous cell carcinoma by suppression subtractive hybridization (123 — 128)

Z. PAN, S. CHEN, X. PAN, Z. WANG, H. HAN, W. ZHENG, X. WANG, F. LI, S. QU, R. SHAO

DOI: 10.4149/neo_2010_02_123

18F-FDG PET/CT in the evaluation of adrenal masses in lung cancer patients (129 — 134)

Y. LU, D. XIE, W. HUANG, H. GONG, J. YU

DOI: 10.4149/neo_2010_02_129

Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma (135 — 144)

G. RADOSAVLJEVIC, B. LJUJIC, I. JOVANOVIC, Z. SRZENTIC, S. PAVLOVIC, N. ZDRAVKOVIC, M. MILOVANOVIC, D. BANKOVIC, M. KNEZEVIC, L. ACIMOVIC, N. ARSENIJEVIC

DOI: 10.4149/neo_2010_02_135

Platelet activation in patients with advanced gastric cancer (145 — 150)

J. OSADA, M. RUSAK, Z. KAMOCKI, M. I. DABROWSKA, B. KEDRA

DOI: 10.4149/neo_2010_02_145

X-irradiation of human bronchial cancer cells causes the bystander effects in normal bronchial cells in vitro (151 — 154)

M. KONOPACKA, J. ROGOLIŃSKI

DOI: 10.4149/neo_2010_02_151

Anaesthesia for radiation therapy – Gliwice experience (155 — 160)

E. WOJCIESZEK, A. REMBIELAK, B. BIALAS, A. WOJCIESZEK

DOI: 10.4149/neo_2010_02_155

The radiosensitising effect of olomoucine derived synthetic cyclin-dependent kinase inhibitors (161 — 169)

G. KORINKOVA, K. CWIERTKA, M. PAPRSKAROVA, P. DZUBAK, M. HAJDUCH

DOI: 10.4149/neo_2010_02_161

Secondary acute myeloid leukemia – a single center experience (170 — 178)

T. SZOTKOWSKI, P. ROHON, L. ZAPLETALOVA, K. SICOVA, J. HUBACEK, K. INDRAK

DOI: 10.4149/neo_2010_02_170

Long-term cardiac effects of treatment for childhood leukemia (179 — 183)

D. URBANOVA, L. URBAN, I. SIMKOVA, K. DANOVA, E. MIKUSKOVA, B. MLADOSIEVICOVA

DOI: 10.4149/neo_2010_02_179

Combination of photodynamic therapy + immunotherapy + chemotherapy in murine leukiemia (184 — 188)

G. CANTI, A. CALASTRETTI, A. BEVILACQUA, E. REDDI, G. PALUMBO, A. NICOLIN

DOI: 10.4149/neo_2010_02_184